Uninsured rate falls in 2014 to lowest point in at least seven years

The uninsured rate fell to 13.8 percent last year, the lowest annualized rate in the seven years of the Gallup-Healthways Well-Being Index measurement.

In 2013, the uninsured rate was 17.3 percent. From 2013 to 2014, no state had a statistically significant increase in its uninsured rate, according to the poll, which conducted daily surveys in all 50 states.

The following states had the largest reductions in their uninsured rate from 2013 to 2014:

  • Arkansas – from 22.5 percent to 11.4 percent
  • Kentucky – from 20.4 percent to 9.8 percent
  • Oregon – from 19.4 percent to 11.7 percent
  • Washington – from 16.8 percent to 10.1 percent
  • West Virginia – from 17.6 percent to 10.9 percent
  • California – from 21.6 percent to 15.3 percent
  • Connecticut – from 12.3 percent to 6.0 percent
  • Colorado – from 17.0 percent to 11.2 percent
  • Maryland – from 12.9 percent to 7.8 percent
  • Montana – from 20.7 percent to 15.8 percent
  • New Mexico – from 20.2 percent to 15.3 percent

Each of those states except for Montana expanded their Medicaid program and started a health insurance exchange in 2014. The 21 states that expanded Medicaid and launched an insurance exchange declined 4.8 percentage points compared with a 2.7 percentage point decrease in the other 29 states.

For the seventh consecutive year, Massachusetts (4.6 percent) had the lowest uninsured rate and Texas (24.4 percent) had the highest uninsured rate.

Read results of the Gallup-Healthways Well-Being Index here.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.